| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.4 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |